Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
In December 1983, following discussions with Dr Savidge, Dr Winter decided to start using heat-treated concentrates (from Alpha) on a named patient basis.
Published on:
27 September, 2024
During December 1983, in relation to Dr Winter's decision to shift to using heat-treated concentrates (from Alpha) on a named patient basis. Dr Winter recalled Professor Bloom's reaction in saying that he was mad to switch as there will never be HIV in BPL Factor VIII.
Published on:
27 September, 2024
The heat-treated concentrates began to be available in May 1984 and from June 1984 the only concentrates being used were heat-treated Factor 8 and 9 both for hospital treatment and home treatment and prophylactically for children.
Published on:
27 September, 2024
Minutes of the ninth meeting of UK Haemophilia Centre Directors' Hepatitis Working Party where Dr Craske presented preliminary data of results from a 4 year surveillance of Factor VIII and IX associated hepatitis, it was recorded that an application had been made to the MRC with a view to a prospective study of patients with mild defects undergoing treatment requiring concentrate cover.
Published on:
27 September, 2024
Supposedly hepatitis-free concentrate was discussed at the twelfth meeting of the Haemophilia Reference Centre Directors. Dr Kernoff stated that this should be used if it were to be introduced into the UK and that the matter should be referred to the Hepatitis Working Party for consideration and recommendation.
Published on:
27 September, 2024
Minutes of the twelfth meeting of the Haemophilia Centre Directors where they received Dr Craske's report on behalf of the Hepatitis Working Party for 1980-81 with its recommendations that surveillance and further studies should continue.
Published on:
27 September, 2024
Haemophilia Centre Directors Hepatitis Working Party Report For Years 1980-81 was published
Published on:
27 September, 2024
Annual Returns for the Newcastle Haemophilia Centre were produced for 1980.
Published on:
27 September, 2024
Annual Returns for the Newcastle Haemophilia Centre were produced for 1981.
Published on:
27 September, 2024
Annual Returns for the Newcastle Haemophilia Centre were produced for 1982.
Published on:
27 September, 2024
Annual Returns for The Royal Free Hospital Haemophilia Centre were produced for 1980.
Published on:
27 September, 2024
Annual Returns for The Royal Free Hospital Haemophilia Centre were produced for 1981.
Published on:
27 September, 2024
Annual Returns for The Royal Free Hospital Haemophilia Centre were produced for 1982.
Published on:
27 September, 2024
Annual Returns for the Cardiff Haemophilia Centre were produced for the year 1980.
Published on:
27 September, 2024
Annual Returns for the Cardiff Haemophilia Centre were produced for the year 1981.
Published on:
27 September, 2024
Annual Returns for the Cardiff Haemophilia Centre were produced for the year 1982.
Published on:
27 September, 2024
Annual Returns for the Belfast Haemophilia Centre were produced for the year 1980.
Published on:
27 September, 2024
Annual Returns for the Belfast Haemophilia Centre were produced for the year 1981.
Published on:
27 September, 2024
At the Belfast Haemophilia Centre, in 1982 patients with Haemophilia A continued to be extensively treated with commercial concentrates.
Published on:
27 September, 2024
At the Belfast Haemophilia Centre, in 1984 patients with Haemophilia A continued to be extensively treated with commercial concentrates.
Published on:
27 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2326
Page
2327
Page
2328
Page
2329
Current page
2330
Page
2331
Page
2332
Page
2333
Page
2334
…
Next page
Next
Last page
Last